Home > News > Recent cases

Actavis v Novartis [2010] EWCA Civ 827 February 2010This was the appeal in the action to revoke Novartis’ patent for its LESCOL® sustained release fluvastatin product. Richard Meade and Mark Chacksfield were instructed by Novartis. The appeal focused in detail on the requirements set down by the House of Lords in the recent Angiotech decision on the question of assessing inventive step.  
Motorola v Research in Motion [2010] EWHC 118 (Pat)3 February 2010Daniel Alexander QC and James Abrahams were part of a team acting for Motorola in substantial multijurisdictional patent litigation with Blackberry manufacturers, Research in Motion, concerning their respective telecoms patents. Three trials were listed between the parties. One was heard in January 2010 and the case settled worldwide on the eve of the second trial […]
Major ICC Arbitration1 December 2009James Mellor QC and Iona Berkeley have just finished two weeks of hearings for a Major ICC Arbitration sitting in London acting for Umbro. The dispute concerned a significant international trade mark licensing dispute with both liability and quantum in issue.
Leo Pharma v. Sandoz [2009] EWCA Civ 118817 November 2009Andrew Lykiardopoulos appeared as junior counsel for Leo Pharma in this appeal concerning the psoriasis treatment Calcipotriol. Leo Pharma was successful in defending its patent and in obtaining injunctive relief. Andrew Lykiardopoulos also appeared at the interim injunction application (where the Court awarded interim injunctive relief) and at the trial.  
R v Hitendra Patel [2009] EWCA Crim 231112 November 2009Martin Howe QC appeared (assisting criminal leader Orlando Pownall QC) in the Court of Appeal (Criminal Division) to argue the points of EU law which arose on the appeal of Hitendra Patel against his conviction for placing a medicinal product on the market without a marketing authorisation. The regulations which created the offence were made […]